Viatris Inc. (VTRS) Stock Analysis — Fair Value, Risk & Moat Rating
NMS · Healthcare · Drug Manufacturers - Specialty & Generic
Is Viatris Inc. a safe investment right now?
Viatris Inc.'s Altman Z-Score of 0.62 places it in the distress zone. Fair value estimate is not available for this stock. Moat rating: 2.3/5 stars.
Could Viatris Inc. go bankrupt? Altman Z-Score analysis
Z-Score of 0.62 falls below the 1.8 distress threshold, indicating significant financial stress.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives VTRS's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.0725 | 1.2 | 0.09 |
| B · Retained Earnings / Total Assets | RE / TA | -0.0104 | 1.4 | -0.01 |
| C · EBIT / Total Assets | EBIT / TA | -0.0859 | 3.3 | -0.28 |
| D · Market Cap / Total Liabilities | MCap / TL | 0.752 | 0.6 | 0.45 |
| E · Revenue / Total Assets | Rev / TA | 0.3845 | 1.0 | 0.38 |
How has VTRS's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 1.14 | Distress |
| 2023 | 1.02 | Distress |
| 2024 | 1.02 | Distress |
| 2025 | 0.62 | Distress |
Source: Calculated from VTRS's latest 10-K filing on SEC EDGAR.
What is Viatris Inc. actually worth?
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Viatris Inc. have a durable competitive advantage?
Moat rating: 2.3/5.
What makes up VTRS's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 2/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 2/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is VTRS's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 8.4% | — |
| 2023 | 2.0% | Declining |
| 2024 | -0.2% | Declining |
| 2025 | -11.0% | Declining |
Source: ROIC calculated from SEC EDGAR filings.
Is Viatris Inc.'s dividend safe?
Can Viatris Inc. afford its dividend?
Payout ratio is 960.0%. FCF covers the dividend 4.3x. 28 consecutive years of payments.
Viatris Inc.'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $14.3B | $14.7B | $16.3B | Declining |
| Net Income | −$3.5B | −$0.6B | $2.1B | Declining |
| Free Cash Flow | $1.9B | $1.9B | $2.5B | Declining |
| Gross Margin | 35.1% | 38.1% | 40.0% | Declining |
Recent events that affect our VTRS analysis
VTRS earnings report scheduled
Upcoming report. Consensus EPS estimate: $0.50. Revenue estimate: $3.36B.
VTRS analyst consensus: 55% bullish (6 of 11 analysts)
1 Strong Buy, 5 Buy, 4 Hold, 0 Sell, 1 Strong Sell. Consensus target: $15.72 (8.3% upside).
VTRS paid $0.1200/share dividend
Dividend Safety Grade: B. Payout ratio: 960.0%.
VTRS beat EPS estimates by 7.4%
Reported EPS: $0.57 vs estimate $0.53.
VTRS filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS paid $0.1200/share dividend
Dividend Safety Grade: B. Payout ratio: 960.0%.
VTRS beat EPS estimates by 8.5%
Reported EPS: $0.67 vs estimate $0.62.
VTRS filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS paid $0.1200/share dividend
Dividend Safety Grade: B. Payout ratio: 960.0%.
VTRS beat EPS estimates by 11.6%
Reported EPS: $0.62 vs estimate $0.56.
VTRS filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS paid $0.1200/share dividend
Dividend Safety Grade: B. Payout ratio: 960.0%.
VTRS beat EPS estimates by 1.6%
Reported EPS: $0.50 vs estimate $0.49.
VTRS filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
VTRS paid $0.1200/share dividend
Dividend Safety Grade: B. Payout ratio: 960.0%.
VTRS missed EPS estimates by 5.6%
Reported EPS: $0.54 vs estimate $0.57.
VTRS filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
VTRS filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Viatris Inc.
What is Viatris Inc. stock price today?
Viatris Inc. (VTRS) stock price is $14.52 as of the latest market close, traded on the NASDAQ exchange.
What does Viatris Inc. do?
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars.
What is Viatris Inc. market cap?
Viatris Inc. has a market capitalization of $16.91B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is VTRS in?
Viatris Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. It trades on the NASDAQ under the ticker symbol VTRS.
Is VTRS stock overvalued or undervalued?
We do not have sufficient earnings data to produce a reliable fair value estimate for Viatris Inc. at this time. Stocks without stable earnings history are difficult to value using traditional models.
What is VTRS stock forecast and analyst target price?
Based on 9 Wall Street analysts, the consensus price target for Viatris Inc. is $15.72, implying upside of 8.3% from the current price.
- Analyst High Target: $20.00
- Analyst Low Target: $12.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Viatris Inc. revenue and earnings growing?
Here are the analyst consensus growth estimates for Viatris Inc.:
- Revenue growth (current year est.): 2.4%
- EPS growth (current year est.): 3.7%
- Revenue growth (next year est.): 1.8%
- EPS growth (next year est.): 9.2%
What are Viatris Inc.'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $14.3B | Declining |
| Net Income | −$3.5B | Declining |
| Free Cash Flow | $1.9B | Declining |
| Gross Margin | 35.1% | Declining |
What is VTRS's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Forward P/E (next 12 months est.): 5.5x
How volatile is VTRS stock?
Viatris Inc. has a beta of 0.82, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Viatris Inc. have?
Viatris Inc.'s balance sheet shows:
- Total Cash: $1.51B
- Total Debt: $14.70B
- Net Cash Position: $-13.19B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Viatris Inc.'s free cash flow?
Viatris Inc. generated $2.43B in trailing twelve-month free cash flow (from $2.32B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Viatris Inc. pay a dividend, and is it safe?
Yes, Viatris Inc. pays a regular dividend. Here are the key metrics:
- Dividend Yield: 3.3%
- Payout Ratio: 960.0%
- Consecutive Years Paid: 28
- 5-Year Dividend Growth: -18.3%
- FairValueLabs Safety Grade: B
Is Viatris Inc. at risk of going bankrupt?
Viatris Inc.'s Altman Z-Score is 0.62, placing it in the distress zone (below 1.8) — elevated bankruptcy risk. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Viatris Inc. have a durable competitive advantage?
Viatris Inc. scores 2.3/5 stars (Weak moat) in our moat analysis:
- ROIC Stability: 2/5
- Gross Margin Trend: 2/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is VTRS's return on equity (ROE)?
Viatris Inc.'s return on equity is -21.1%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy VTRS stock?
VTRS shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol VTRS
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is VTRS a value stock or speculative?
FairValueLabs classifies Viatris Inc. as Value-Speculation. It has some value characteristics but carries elevated risk factors that make it speculative. Extra due diligence is recommended.
Who is the CEO of Viatris Inc.?
The current CEO of Viatris Inc. is Mr. Scott Andrew Smith Ph.D..
What is VTRS's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $-3.00
- Forward EPS (next 12 months est.): $2.66
- Analyst consensus EPS (this year): $2.44
- Analyst consensus EPS (next year): $2.66
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
VTRS analysis methodology: How we calculate fair value, Z-Scores, and moat ratings